Filing Details
- Accession Number:
- 0001593968-21-000706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 16:15:13
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-02 16:15:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1313403 | Dominick Colangelo | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-01 | 1,548 | $48.47 | 217,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-01 | 2,260 | $48.78 | 215,387 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 5,625 | $2.65 | 221,012 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 6,805 | $7.20 | 227,817 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 15,925 | $2.75 | 243,742 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 27,500 | $48.06 | 216,242 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-01 | 8,692 | $48.01 | 207,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 5,625 | $0.00 | 5,625 | $2.65 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 6,805 | $0.00 | 6,805 | $7.20 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 15,925 | $0.00 | 15,925 | $2.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,125 | 2027-05-22 | No | 4 | M | Direct | |
| 293,195 | 2028-02-07 | No | 4 | M | Direct | |
| 49,700 | 2027-02-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
- 6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company.
- These options, representing the right to purchase a total of 300,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted.
- These options, representing the right to purchase a total of 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.
Billionaire Hedge Funds
